LAUREN LEVY: Open Payments
NPI 1104276641 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,600 in 104 payments from 12 companies in 2025. Trend: 2023 $1,327 · 2024 $1,260 · 2025 $1,600
Food & beverage: $1,595Education: $5
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $301 |
| Alkermes, Inc. | 11 | $233 |
| Otsuka America Pharmaceutical, Inc. | 18 | $193 |
| Teva Pharmaceuticals USA, Inc. | 16 | $191 |
| ABBVIE INC. | 14 | $172 |
| Janssen Pharmaceuticals, Inc | 12 | $162 |
| Neurocrine BioSciences, Inc. | 6 | $113 |
| Vanda Pharmaceuticals Inc. | 6 | $104 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $76 |
| Celgene Corporation | 1 | $22 |
Products named: COBENFY, ARISTADA, VRAYLAR, INVEGA SUSTENNA, REXULTI, INGREZZA, UZEDY, AUSTEDO XR.
Industry payments across SC — which companies pay providers there.
